Opiant Pharmaceuticals, Inc. (OPNT)

USD 20.65

(0.0%)

Market Cap (In USD)

108.79 Million

Revenue (In USD)

40.72 Million

Net Income (In USD)

3 Million

Avg. Volume

72.35 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7.34-27.36
PE
-3.1623
EPS
-6.53
Beta Value
0.831589
ISIN
US6837501039
CUSIP
683750103
CIK
1385508
Shares
5268680.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Roger Crystal M.D.
Employee Count
-
Website
https://www.opiant.com
Ipo Date
2007-06-04
Details
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.